One woman’s journey from receiving her diagnosis to finding a treatment that helps manage her chronic skin condition.

Plaques are pink/red, raised, thick, inflamed skin patches covered by silvery-white scales. They typically have well-defined ...

which may lead to the development of new psoriatic lesions (Koebner phenomenon). Patients should also be informed about the potential for developing chronic plaque-type psoriasis. Education about ...

Plaque psoriasis is characterized by raised ... dot-like spots on the body. These lesions frequently appear on the upper arms, trunk, thighs, or scalp. Often, this form of psoriasis starts ...

Statistically significant improvements were also achieved across all major secondary endpoints, including: 52.9% achieved a Psoriasis Area Severity Index (PASI) 90 response compared to 6.2% of ...

Linda Stein Gold, MD, Director of Dermatology Clinical Research at Henry Ford Health, and SPECTREM investigator said, “People who have special site plaque psoriasis with lesions that cover a ...

Research shows lifestyle changes like diet, exercise, and smoking cessation can assist with improving psoriasis outcomes and ...

A phase 2b, long-term extension, dose-ranging study of oral JNJ-77242113 for the treatment of moderate-to-severe plaque psoriasis,” published in the November 2024 issue of Dermatology by Ferris et al.

1 "People who have special site plaque psoriasis with lesions that cover a smaller total area of their body are often only prescribed topical treatments and not considered candidates for advanced ...

Even though he suffers from psoriasis, Joel Thomas considers himself a lucky man. Psoriasis is a chronic skin disorder that affects over seven and a half million Americans. Many are not as lucky ...

There is an erythematous, slightly indurated plaque on the anterior right ... Injections should not be administered into psoriasis skin lesions. Signs and symptoms of infection should be reviewed ...

moderate plaque psoriasis (PsO) with special site involvement who had failed topical treatment. Data from the Phase 3b SPECTREM study to measure skin clearance and other treatment outcomes in low ...